Press & Insights

All

As of February 11, 2025, Cresset Partners is known as Peakline Partners. Please note some articles and press releases still reference Cresset Partners in the context of historical and time-sensitive business updates.

How to Get Started in Private Investing: 5 Things to Know

Published October 2023. “How to get started in private investing?” It’s a popular search phrase in Google for good reason. An increasing number of investors

Getting to Know Our CPEO Fund

Published October 2023. Private equity has long appealed to investors seeking the potential for outsized investment returns, albeit with a longer time horizon and higher

Investing IRA and Retirement Assets in Private Funds: What Investors Need to Know

Published October 2023. Did you know that you can use retirement assets, including an individual retirement account (IRA) or 401(k), to invest in private assets

Private Equity Versus “Patient Capital”: What Entrepreneurs and Investors Need to Know

Published May 2023. For business owners seeking capital, and for investors looking to increase their allocations to private markets, there are different alternatives available, including

The 3 Types of Private Investors: Which one are you?

Published April 2023. Private investments have historically provided investors with outsized returns compared to public markets, without the angst of daily volatility. That said, securities

Reasons to Invest in Private Markets During Times of High Volatility

Published January 2023. Portfolios with higher allocations to private investments outperform Private market investing may offer benefits like an enhanced risk-return profile and further diversification

We use cookies to improve your web experience, analyze site usage, and deliver personalized content to you. Some cookies are essential to site functionality, others are optional and help us see how the site is used or allow us to better service you.  By clicking “Accept” you are accepting all cookies. To better understand how cookies are used by us or to opt-out, visit Terms of Use.